Linkedin Share
News

New Study Shreds Vaccine Efficacy Expectations, Could Reinforce Reluctancy

Linkedin Share

The longstanding debate over the safety and efficacy of COVID-19 vaccinations continues to rumble through American culture these days, with only about 56% of citizens having been fully vaccinated at this point.

And there are many different reasons for the reluctancy, some of which are abjectly absurd and borderline conspiratorial.  These are the sentiments that the mainstream media loves to lampoon night after night.

But then there are the more mundane, plausible-sounding worries, about the vaccine’s safety and efficacy.  Some believe that the shots were developed too quickly, and rushed through the approval processes.  Others worry that their effects won’t last, and that we’ll just keep getting COVID shots, year after year after year.

A new study is now lending some credence to those concerns.

Two real-world studies published Wednesday confirm that the immune protection offered by two doses of Pfizer’s Covid-19 vaccine drops off after two months or so, although protection against severe disease, hospitalization and death remains strong.

Trending:
Massive Migrant Caravan Marches Toward US with LGBT Flags Flying as Mexican President Snubs Biden at Summit

The studies, from Israel and from Qatar and published in the New England Journal of Medicine, support arguments that even fully vaccinated people need to maintain precautions against infection.

One study from Israel covered 4,800 health care workers and showed antibody levels wane rapidly after two doses of vaccine “especially among men, among persons 65 years of age or older, and among persons with immunosuppression.”

Another intriguing fact came to light as well.

The study also indicated that immunity for people who get vaccinated after natural Covid-19 infection lasts longer. It’s especially strong for people who recovered from infection and then got vaccinated, also. “Overall, the accumulating evidence from our study and others shows that long-term humoral response and vaccine effectiveness in previously infected persons were superior to that in recipients of two doses of vaccine,” they wrote.

One can only imagine that those who are opposed to receiving one or two doses of the vaccine are not likely to be keen on the idea of perpetual booster shots either.

Submit a Correction →



Tags:
Linkedin Share
About the Author:
As a lifelong advocate for the dream promised us in the Constitution, Andrew West has spent his years authoring lush prose editorial dirges regarding America's fall from grace and her path back to prosperity. When West isn't railing against the offensive whims of the mainstream media or the ideological cruelty that is so rampant in the US, he spends his time seeking adventurous new food and fermented beverages, with the occasional round of golf peppered in.




Conversation